Genesis Therapeutics is an innovative biotechnology company that operates at the intersection of artificial intelligence and biochemistry. Comprising a dedicated team of deep learning researchers, software engineers, and drug discovery experts, the company is committed to developing next-generation AI foundation models aimed at revolutionizing therapies for patients with severe diseases. By conducting fundamental research that integrates machine learning, physics, and computational chemistry, Genesis Therapeutics is pushing the boundaries of scientific discovery. The company fosters a collaborative environment where multidisciplinary researchers work together to design scalable generative models, ultimately enhancing drug discovery processes and delivering impactful solutions to the healthcare sector.